Evidence map›Paper›PMID 41809082›Full record

ReviewRSC advances2026

Advances in NP shapes and their applications in cancer therapy.

Xiaoqian Li, Junqing Li, Yimer Seid Ali, Jianjun Ji, Xiaohong Wen, Fang Wu, Chuanpin Chen

Abstract readReview
In one paragraph

Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaoqian LiXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China ccpin2000@hotmail.com.
Junqing LiXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China ccpin2000@hotmail.com.
Yimer Seid AliXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China ccpin2000@hotmail.com.
Jianjun JiZhejiang Provincial People's Hospital Hangzhou 310014 China.
Xiaohong WenXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China ccpin2000@hotmail.com.
Fang WuDepartment of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000 China.
Chuanpin ChenXiangya School of Pharmaceutical Sciences, Central South University Changsha 410013 China ccpin2000@hotmail.com.ORCID https://orcid.org/0000-0001-8094-1270

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a major global cause of death, yet traditional treatments such as surgery, chemotherapy, and radiotherapy have inherent limitations. Nanoparticles (NPs) are rapidly emerging as drug delivery systems for cancer treatments, offering promising advancements to overcome associated challenges and enhance therapies. Innovation in nanoparticle shapes is crucial in nanotechnology research worldwide. Studies indicate that the shape of nanoparticles can affect their tumor-targeting efficiency and blood circulation time. For example, the tumor accumulation of nanorods is reported to be 3-5-times higher than that of nanospheres, while the blood circulation time of nanodisks can be extended by 2-3-times compared to nanospheres. In this review, we first introduce different shapes of nanoparticles, illustrate their fabrication processes, and present their applications. Then, we examine recent research on NP shapes for various cancer treatments, discussing their challenges, perspectives, and potential impact on oncology and offering a deeper understanding.

Identifiers

PMID41809082
PMCPMC12969992

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.